Page 80 - 南京医科大学学报自然科学版
P. 80

第43卷第3期
               ·370 ·                            南 京    医 科 大 学 学         报                        2023年3月


                   Rev Cancer,2020,20(6):323-342                     new prognostic model developed by the International T
             [4] FRANCESCO M,LUCA A,DANIEL L,et al. Integration      cell Project Network[J]. Br J Haematol,2018,181(6):
                   of transcriptional and mutational data simplifies the strati⁃  760-769
                   fication of peripheral T⁃cell lymphoma[J]. Am J Hema⁃  [12] EDGREN G,BAGNARDI V,BELLOCCO R,et al. Pat⁃
                   tol,2019,94(6):628-634                            tern of declining hemoglobin concentration before cancer
             [5] MA H,MARCHI E,O’CONNOR O A. The peripheral T⁃       diagnosis[J]. Int J Cancer,2010,127(6):1429-1436
                   cell lymphomas:an unusual path to cure[J]. The Lancet  [13] ZHU Q,TANNENBAUM S,KURTZMAN S H,et al. Iden⁃
                   Haematology,2020,7(10):765-771                    tifying an early treatment window for predicting breast
             [6] WILCOX R A. Cutaneous B ⁃ cell lymphomas:2015 up⁃   cancer response to neoadjuvant chemotherapy using im⁃
                   date on diagnosis,risk ⁃ stratification,and management  munohistopathology and hemoglobin parameters [J].
                  [J]. Am J Hematol,2015,90(1):73-76                 Breast Cancer Res,2018,20(1):56
             [7] WULF G G,BETTINA A,MARITA Z,et al. Alemtuzumab  [14] CARLOS M,VÍCTOR A,LUCA A,et al. Risk stratifica⁃
                   plus CHOP versus CHOP in elderly patients with periph⁃  tion for splenic marginal zone lymphoma based on haemo⁃
                   eral T⁃cell lymphoma:the DSHNHL2006⁃1B/ACT⁃2 trial  globin concentration,platelet count,high lactate dehydro⁃
                  [J]. Leukemia,2020,35(1):143-155                   genase level and extrahilar lymphadenopathy:develop⁃
             [8] KEMPF W,MITTELDORF C,BATTISTELLA M,et al.           ment and validation on 593 cases[J]. Br J Haematol,
                   Primary cutaneous peripheral T⁃cell lymphoma,not other⁃  2012,159(2):164-171
                   wise specified:results of a multicentre European Organi⁃  [15] LE M,GARCILAZO Y,IBANEZ⁃JULIA M J,et al. Pre⁃
                   zation for Research and Treatment of Cancer(EORTC)  treatment hemoglobin as an independent prognostic factor
                   cutaneous lymphoma taskforce study on the clinico⁃patho⁃  in primary central nervous system lymphomas[J]. Oncolo⁃
                   logical and prognostic features[J]. J Eur Acad Dermatol  gist,2019,24(9):898-904
                   Venereol,2021,35(3):658-668                  [16] ABDEL⁃RAZEQ H,HASHEM H. Recent update in the
             [9] FOLEY N C,MEHTA⁃SHAH N. Management of peripher⁃     pathogenesis and treatment of chemotherapy and cancer
                   al T⁃cell lymphomas and the role of transplant[J]. Curr  induced anemia[J]. Crit Rev Oncol Hematol,2020,145
                   Oncol Rep,2022,24(11):1489-1499                  (10):28-37
             [10] ANDREA G,CATERINA S,ROBERTA C,et al. Periph⁃  [17] LANSER L,KINK P,EGGER E M,et al. Inflammation⁃in⁃
                   eral T⁃cell lymphoma unspecified(PTCL⁃U):a new prog⁃  duced tryptophan breakdown is related with anemia,fa⁃
                   nostic model from a retrospective multicentric clinical  tigue,and depression in cancer[J]. Front Immunol,2020,
                   study[J]. Blood,2004,103(7):2474-2479             11:249
             [11] MASSIMO F,MONICA B,LUIGI M,et al. Peripheral T                          [收稿日期] 2022-11-01
                   cell lymphoma,not otherwise specified(PTCL ⁃ NOS).A                         (本文编辑:陈汐敏)
   75   76   77   78   79   80   81   82   83   84   85